Endotoxin: A Bona Fide Treatable Sepsis Endotype? Available to Purchase

3.

Kaukonen

KM

,

Bailey

M

,

Suzuki

S

,

Pilcher

D

,

Bellomo

R

.

Mortality related to severe sepsis and septic shock among critically ill patients in Australia and New Zealand, 2000-2012

.

JAMA

.

2014

;

311

(

13

):

1308

–

16

.

4.

Leligdowicz

A

,

Matthay

MA

.

Heterogeneity in sepsis: new biological evidence with clinical applications

.

Crit Care

.

2019

;

23

(

1

):

80

.

5.

Seymour

CW

,

Kennedy

JN

,

Wang

S

,

Chang

CH

,

Elliott

CF

,

Xu

Z

, et al.

Derivation, validation, and potential treatment implications of novel clinical phenotypes for sepsis

.

JAMA

.

2019

;

321

(

20

):

2003

–

17

.

6.

Seymour

CW

,

Gomez

H

,

Chang

C-CH

,

Clermont

G

,

Kellum

JA

,

Kennedy

J

, et al.

Precision medicine for all? Challenges and opportunities for a precision medicine approach to critical illness

.

Crit Care

.

2017

;

21

(

1

):

257

.

7.

Sinha

P

,

Meyer

NJ

,

Calfee

CS

.

Biological phenotyping in sepsis and acute respiratory distress syndrome

.

Annu Rev Med

.

2023

;

74

:

457

–

71

.

8.

van Amstel

RBE

,

Kennedy

JN

,

Scicluna

BP

,

Bos

LDJ

,

Peters-Sengers

H

,

Butler

JM

, et al.

Uncovering heterogeneity in sepsis: a comparative analysis of subphenotypes

.

Intensive Care Med

.

2023

;

49

(

11

):

1360

–

9

.

9.

Zarbock

A

,

Nadim

MK

,

Pickkers

P

,

Gomez

H

,

Bell

S

,

Joannidis

M

, et al.

Sepsis-associated acute kidney injury: consensus report of the 28th Acute Disease Quality Initiative workgroup

.

Nat Rev Nephrol

.

2023

;

19

(

6

):

401

–

17

.

10.

Legrand

M

,

Bagshaw

SM

,

Bhatraju

PK

,

Bihorac

A

,

Caniglia

E

,

Khanna

AK

, et al.

Sepsis-associated acute kidney injury: recent advances in enrichment strategies, sub-phenotyping and clinical trials

.

Crit Care

.

2024

;

28

(

1

):

92

.

11.

Anderson

GP

.

Endotyping asthma: new insights into key pathogenic mechanisms in a complex, heterogeneous disease

.

Lancet

.

2008

;

372

(

9643

):

1107

–

19

.

12.

Battaglia

M

,

Ahmed

S

,

Anderson

MS

,

Atkinson

MA

,

Becker

D

,

Bingley

PJ

, et al.

Introducing the endotype concept to address the challenge of disease heterogeneity in type 1 diabetes

.

Diabetes Care

.

2020

;

43

(

1

):

5

–

12

.

13.

Daniels

IR

.

Historical perspectives on health

.

J R Soc Promot Health

.

1998

;

118

(

6

):

367

–

70

.

14.

Hutchings

MI

,

Truman

AW

,

Wilkinson

B

.

Antibiotics: past, present and future

.

Curr Opin Microbiol

.

2019

;

51

:

72

–

80

.

15.

Maslove

DM

,

Tang

B

,

Shankar-Hari

M

,

Lawler

PR

,

Angus

DC

,

Baillie

JK

, et al.

Redefining critical illness

.

Nat Med

.

2022

;

28

(

6

):

1141

–

8

.

16.

Baillie

JK

,

Angus

D

,

Burnham

K

,

Calandra

T

,

Calfee

C

,

Gutteridge

A

, et al.

Causal inference can lead us to modifiable mechanisms and informative archetypes in sepsis

.

Intensive Care Med

.

2024

;

50

(

12

):

2031

–

42

.

17.

Bauer

M

,

Gerlach

H

,

Vogelmann

T

,

Preissing

F

,

Stiefel

J

,

Adam

D

.

Mortality in sepsis and septic shock in Europe, North America and Australia between 2009 and 2019- results from a systematic review and meta-analysis

.

Crit Care

.

2020

;

24

(

1

):

239

.

18.

Marshall

JC

,

Foster

D

,

Vincent

JL

,

Cook

DJ

,

Cohen

J

,

Dellinger

RP

, et al.

Diagnostic and prognostic implications of endotoxemia in critical illness: results of the MEDIC study

.

J Infect Dis

.

2004

;

190

(

3

):

527

–

34

.

19.

Adamik

B

,

Smiechowicz

J

,

Jakubczyk

D

,

Kübler

A

.

Elevated serum PCT in septic shock with endotoxemia is associated with a higher mortality rate

.

Medicine

.

2015

;

94

(

27

):

e1085

.

20.

Adamik

B

,

Smiechowicz

J

,

Kübler

A

.

The importance of early detection of endotoxemia

.

Innate Immun

.

2016

;

22

(

7

):

503

–

9

.

21.

Kellum

JA

,

Ronco

C

.

The role of endotoxin in septic shock

.

Crit Care

.

2023

;

27

(

1

):

400

.

22.

Virzì

GM

,

Mattiotti

M

,

de Cal

M

,

Ronco

C

,

Zanella

M

,

De Rosa

S

.

Endotoxin in sepsis: methods for LPS detection and the use of omics techniques

.

Diagnostics

.

2022

;

13

(

1

):

79

.

23.

Foster

DM

,

Kellum

JA

.

Endotoxic septic shock: diagnosis and treatment

.

Int J Mol Sci

.

2023

;

24

(

22

):

16185

.

24.

Romaschin

AD

,

Klein

DJ

,

Marshall

JC

.

Bench-to-bedside review: clinical experience with the endotoxin activity assay

.

Crit Care

.

2012

;

16

(

6

):

248

.

25.

Kritselis

I

,

Tzanetakou

V

,

Adamis

G

,

Anthopoulos

G

,

Antoniadou

E

,

Bristianou

M

, et al.

The level of endotoxemia in sepsis varies in relation to the underlying infection: impact on final outcome

.

Immunol Lett

.

2013

;

152

(

2

):

167

–

72

.

26.

Sirivongrangson

P

,

Kulvichit

W

,

Payungporn

S

,

Pisitkun

T

,

Chindamporn

A

,

Peerapornratana

S

, et al.

Endotoxemia and circulating bacteriome in severe COVID-19 patients

.

Intensive Care Med Exp

.

2020

;

8

(

1

):

72

.

27.

van Deventer

SJ

,

ten Cate

JW

,

Tytgat

GN

.

Intestinal endotoxemia. Clinical significance

.

Gastroenterology

.

1988

;

94

(

3

):

825

–

31

.

28.

Clark

JA

,

Coopersmith

CM

.

Intestinal crosstalk: a new paradigm for understanding the gut as the “motor” of critical illness

.

Shock

.

2007

;

28

(

4

):

384

–

93

.

29.

Cavaillon

JM

,

Singer

M

,

Skirecki

T

.

Sepsis therapies: learning from 30 years of failure of translational research to propose new leads

.

EMBO Mol Med

.

2020

;

12

(

4

):

e10128

.

30.

Payen

DM

,

Guilhot

J

,

Launey

Y

,

Lukaszewicz

AC

,

Kaaki

M

,

Veber

B

, et al.

Early use of polymyxin B hemoperfusion in patients with septic shock due to peritonitis: a multicenter randomized control trial

.

Intensive Care Med

.

2015

;

41

(

6

):

975

–

84

.

31.

Dellinger

RP

,

Bagshaw

SM

,

Antonelli

M

,

Foster

DM

,

Klein

DJ

,

Marshall

JC

, et al.

Effect of targeted polymyxin B hemoperfusion on 28-day mortality in patients with septic shock and elevated endotoxin level: the EUPHRATES randomized clinical trial

.

JAMA

.

2018

;

320

(

14

):

1455

–

63

.

32.

Klein

DJ

,

Foster

D

,

Walker

PM

,

Bagshaw

SM

,

Mekonnen

H

,

Antonelli

M

.

Polymyxin B hemoperfusion in endotoxemic septic shock patients without extreme endotoxemia: a post hoc analysis of the EUPHRATES trial

.

Intensive Care Med

.

2018

;

44

(

12

):

2205

–

12

.

33.

Tomlinson

G

,

Al-Khafaji

A

,

Conrad

SA

,

Factora

FNF

,

Foster

DM

,

Galphin

C

, et al.

Bayesian methods: a potential path forward for sepsis trials

.

Crit Care

.

2023

;

27

(

1

):

432

.

34.

Shoji

H

,

Opal

SM

.

Therapeutic rationale for endotoxin removal with polymyxin B immobilized fiber column (PMX) for septic shock

.

Int J Mol Sci

.

2021

;

22

(

4

):

2228

.

35.

Klein

G

,

Raina

S

.

Regulated assembly of LPS, its structural alterations and cellular response to LPS defects

.

Int J Mol Sci

.

2019

;

20

(

2

):

356

.

36.

Davies

B

,

Cohen

J

.

Endotoxin removal devices for the treatment of sepsis and septic shock

.

Lancet Infect Dis

.

2011

;

11

(

1

):

65

–

71

.

37.

Wang

M

,

Feng

J

,

Zhou

D

,

Wang

J

.

Bacterial lipopolysaccharide-induced endothelial activation and dysfunction: a new predictive and therapeutic paradigm for sepsis

.

Eur J Med Res

.

2023

;

28

(

1

):

339

.

38.

Fitzgerald

KA

,

Kagan

JC

.

Toll-like receptors and the control of immunity

.

Cell

.

2020

;

180

(

6

):

1044

–

66

.

39.

Wurfel

MM

,

Wright

SD

.

Lipopolysaccharide-binding protein and soluble CD14 transfer lipopolysaccharide to phospholipid bilayers: preferential interaction with particular classes of lipid

.

J Immunol

.

1997

;

158

(

8

):

3925

–

34

.

40.

Park

BS

,

Song

DH

,

Kim

HM

,

Choi

BS

,

Lee

H

,

Lee

JO

.

The structural basis of lipopolysaccharide recognition by the TLR4-MD-2 complex

.

Nature

.

2009

;

458

(

7242

):

1191

–

5

.

41.

Fitzgerald

KA

,

Palsson-McDermott

EM

,

Bowie

AG

,

Jefferies

CA

,

Mansell

AS

,

Brady

G

, et al.

Mal (MyD88-adapter-like) is required for Toll-like receptor-4 signal transduction

.

Nature

.

2001

;

413

(

6851

):

78

–

83

.

42.

Horng

T

,

Barton

GM

,

Medzhitov

R

.

TIRAP: an adapter molecule in the Toll signaling pathway

.

Nat Immunol

.

2001

;

2

(

9

):

835

–

41

.

43.

Kagan

JC

,

Magupalli

VG

,

Wu

H

.

SMOCs: supramolecular organizing centres that control innate immunity

.

Nat Rev Immunol

.

2014

;

14

(

12

):

821

–

6

.

44.

Akashi

S

,

Shimazu

R

,

Ogata

H

,

Nagai

Y

,

Takeda

K

,

Kimoto

M

, et al.

Cutting edge: cell surface expression and lipopolysaccharide signaling via the toll-like receptor 4-MD-2 complex on mouse peritoneal macrophages

.

J Immunol

.

2000

;

164

(

7

):

3471

–

5

.

45.

Zanoni

I

,

Spreafico

R

,

Bodio

C

,

Di Gioia

M

,

Cigni

C

,

Broggi

A

, et al.

IL-15 cis presentation is required for optimal NK cell activation in lipopolysaccharide-mediated inflammatory conditions

.

Cell Rep

.

2013

;

4

(

6

):

1235

–

49

.

46.

Janosevic

D

,

Myslinski

J

,

McCarthy

TW

,

Zollman

A

,

Syed

F

,

Xuei

X

, et al.

The orchestrated cellular and molecular responses of the kidney to endotoxin define a precise sepsis timeline

.

Elife

.

2021

;

10

:

10

.

47.

Hato

T

,

Maier

B

,

Syed

F

,

Myslinski

J

,

Zollman

A

,

Plotkin

Z

, et al.

Bacterial sepsis triggers an antiviral response that causes translation shutdown

.

J Clin Investig

.

2019

;

129

(

1

):

296

–

309

.

48.

Seok

J

,

Warren

HS

,

Cuenca

AG

,

Mindrinos

MN

,

Baker

HV

,

Xu

W

, et al.

Genomic responses in mouse models poorly mimic human inflammatory diseases

.

Proc Natl Acad Sci USA

.

2013

;

110

(

9

):

3507

–

12

.

49.

Osuchowski

MF

,

Remick

DG

,

Lederer

JA

,

Lang

CH

,

Aasen

AO

,

Aibiki

M

, et al.

Abandon the mouse research ship

.

Shock

.

2014

;

41

(

6

):

463

–

75

.

50.

Matthay

MA

,

Schmidt

EP

,

Bastarache

JA

,

Calfee

CS

,

Frevert

CW

,

Martin

TR

.

The translational value of rodent models of sepsis

.

Am J Respir Crit Care Med

.

2024

;

209

(

5

):

488

–

90

.

51.

Kiers

D

,

Koch

RM

,

Hamers

L

,

Gerretsen

J

,

Thijs

EJ

,

van Ede

L

, et al.

Characterization of a model of systemic inflammation in humans in vivo elicited by continuous infusion of endotoxin

.

Sci Rep

.

2017

;

7

:

40149

.

52.

Suffredini

AF

,

Fromm

RE

,

Parker

MM

,

Brenner

M

,

Kovacs

JA

,

Wesley

RA

, et al.

The cardiovascular response of normal humans to the administration of endotoxin

.

N Engl J Med

.

1989

;

321

(

5

):

280

–

7

.

53.

van Bockel

EA

,

Tulleken

JE

,

Muller Kobold

AC

,

Ligtenberg

JJ

,

van der Werf

TS

,

Spanjersberg

R

, et al.

Cardiac troponin I release and cytokine response during experimental human endotoxaemia

.

Intensive Care Med

.

2003

;

29

(

9

):

1598

–

600

.

54.

Bahador

M

,

Cross

AS

.

From therapy to experimental model: a hundred years of endotoxin administration to human subjects

.

J Endotoxin Res

.

2007

;

13

(

5

):

251

–

79

.

55.

van Lier

D

,

Geven

C

,

Leijte

GP

,

Pickkers

P

.

Experimental human endotoxemia as a model of systemic inflammation

.

Biochimie

.

2019

;

159

:

99

–

106

.

56.

O’Dwyer

ST

,

Michie

HR

,

Ziegler

TR

,

Revhaug

A

,

Smith

RJ

,

Wilmore

DW

.

A single dose of endotoxin increases intestinal permeability in healthy humans

.

Arch Surg

.

1988

;

123

(

12

):

1459

–

64

.

57.

Jørgensen

VL

,

Ibsen

M

,

Andresen

L

,

Schulzke

JD

,

Perner

A

.

Effects of endotoxaemia on markers of permeability, metabolism and inflammation in the large bowel of healthy subjects

.

Acta Anaesthesiol Scand

.

2007

;

51

(

8

):

1085

–

92

.

58.

Hietbrink

F

,

Besselink

MG

,

Renooij

W

,

de Smet

MB

,

Draisma

A

,

van der Hoeven

H

, et al.

Systemic inflammation increases intestinal permeability during experimental human endotoxemia

.

Shock

.

2009

;

32

(

4

):

374

–

8

.

59.

Ramakers

BP

,

de Goeij

M

,

van der Hoeven

JG

,

Peters

WH

,

Pickkers

P

.

Inflammation-induced hepatotoxicity in humans

.

Shock

.

2009

;

31

(

2

):

151

–

6

.

60.

Taveira da Silva

AM

,

Kaulbach

HC

,

Chuidian

FS

,

Lambert

DR

,

Suffredini

AF

,

Danner

RL

.

Brief report: shock and multiple-organ dysfunction after self-administration of Salmonella endotoxin

.

N Engl J Med

.

1993

;

328

(

20

):

1457

–

60

.

61.

Tidswell

M

,

Tillis

W

,

Larosa

SP

,

Lynn

M

,

Wittek

AE

,

Kao

R

, et al.

Phase 2 trial of eritoran tetrasodium (E5564), a toll-like receptor 4 antagonist, in patients with severe sepsis

.

Crit Care Med

.

2010

;

38

(

1

):

72

–

83

.

62.

Cohen

J

,

Aslam

M

,

Pusey

CD

,

Ryan

CJ

.

Protection from endotoxemia: a rat model of plasmapheresis and specific adsorption with polymyxin B

.

J Infect Dis

.

1987

;

155

(

4

):

690

–

5

.

63.

Fujimori

K

,

Tarasawa

K

,

Fushimi

K

.

Effects of polymyxin B hemoperfusion on septic shock patients requiring noradrenaline: analysis of a nationwide administrative database in Japan

.

Blood Purif

.

2021

;

50

(

4–5

):

560

–

5

.

64.

Li

X

,

Liu

C

,

Mao

Z

,

Qi

S

,

Song

R

,

Zhou

F

.

Effectiveness of polymyxin B-immobilized hemoperfusion against sepsis and septic shock: a systematic review and meta-analysis

.

J Crit Care

.

2021

;

63

:

187

–

95

.

65.

Li

C

,

Zhang

J

,

Yang

P

,

Wang

R

,

Chen

T

,

Li

L

.

The role of polymyxin B-immobilized hemoperfusion in reducing mortality and enhancing hemodynamics in patients with sepsis and septic shock: a systematic review and meta-analysis

.

Heliyon

.

2024

;

10

(

13

):

e33735

.